Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Biomea Fusion, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 44 | 39 | −5 |
| Shares | 16.5M | 17.1M | +669.7K (+4.1%) |
| Value | $253.9M | $204.5M | −$49.4M (−19.5%) |
New holders (2)
Institutions that held Biomea Fusion, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Evolution Wealth Advisors, LLC | 319 | $4.00K | 0.00% |
| UBS Group AG | 100 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Biomea Fusion, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 248,447 | $3.88M |
| Franklin Resources Inc | 200,000 | $3.12M |
| Citadel Advisors LLC | 19,491 | $304.0K |
| Zimmer Partners, LP | 10,000 | $156.0K |
| Caas Capital Management LP | 10,000 | $156.0K |
| Pinz Capital Management, LP | 4,850 | $76.0K |
| US Bancorp | 33 | $1.00K |